Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Understanding the differences between value and growth investing is essential. Learn how to choose the right approach for your goals.
24,909 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A major biotech acquisition news drove a sharp move in ATAI shares. This article breaks down why ataibeckley stock so...
Many Americans say peace of mind is worth more than big splurges. This guide breaks down what that means for real wal...
Income-focused investors flock to AGNC for its big dividend, but the real driver of long-term value is its net intere...
CONY’s eye-popping payouts mask a much steeper NAV decline. A 37% drop since inception signals a structural risk behi...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...
Meme-driven moves are steering crypto markets, with XMR vs ZEC taking center stage. This piece breaks down how rate-c...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
Bank-owned properties are climbing fast. This guide explains why the 25.7% increase matters, how it reshapes pricing ...
When high-level insiders transact, it sparks questions. This article explains what medical's general counsel sells si...
Bill Gates manages a massive charitable portfolio with a striking concentration: about 30% of its value sits in a sin...
A sharp intraday drop and quick questions about the company’s outlook have many traders rethinking positions. This gu...